Scripps Florida Scientists Develop Novel Platform for Treatment of Breast, Pancreatic Cancer
16 January, 2015
A team led by scientists at The Scripps Research Institute (TSRI) has identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited neurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that inhibit this enzyme.
15 January, 2015
CANCER RESEARCH UK scientists have taken steps to overcome drug resistance in glioblastoma, the most common type of brain tumour in adults, according to research published in Molecular Cancer Therapeutics today (Wednesday).
14 January, 2015
MedCity Executive Chair Dr Eliot Forster has been announced as the new chief executive officer of Immunocore, a leading Oxford-based biotech company focused on the discovery and development of novel cancer therapies.
13 January, 2015